Kat’s story is about reducing PS volume
With the help of GATTEX, my doctor was able to cut my weekly PS. I’m now infusing fewer liters of PS a week.
-Kat, Gattex patient
Peggy's story is about achieving time off PS
Now, I spend my days off PS engaged in pastimes like being with friends, traveling, and engaging in volunteer activities.
-Peggy, Gattex patient
Betsy’s story is about achieving freedom from PS
Over time with GATTEX, my doctors started slowly reducing my PS. A year later, my PS had been stopped altogether.
-Betsy, Gattex patient
In a 6-month study, 27 out of 43 adults treated with GATTEX reduced weekly PS volume by 20% or more vs 13 out of 43 on placebo, and 21 out of 39 achieved at least 1 day off PS per week vs 9 out of 39 on placebo. After 30 months of treatment, 10 out of 30 adults no longer needed PS. In a 6-month study, 18 out of 26 children treated with GATTEX reduced weekly PS volume by 20% or more, 10 out of 26 achieved a reduction of at least 1 day off PS per week, and 3 out of 26 no longer needed PS.
SBS Patient Ambassadors are adults with short bowel syndrome who know what it’s like to be dependent on parenteral support (PS) and who have experience taking GATTEX. Through SBS Connect, talk one on one with a Patient Ambassador as they share their experiences of living with SBS and journey from diagnosis to treatment.
Always remember that individual experiences and results will vary. The SBS Connect Program is not intended for the purpose of disease diagnosis. It is not a substitute for information that is provided to you by your physician. You should always discuss your medical condition and any questions you have with your physician.
With OnePath, each eligible patient is partnered with a dedicated Patient Support Manager and an Onboarding and Access Specialist (OAS) who can assist with many aspects of treatment, including:
Navigating health insurance
Providing information about financial assistance options
Coordinating free injection training, if requested by the healthcare professional
Working with the specialty pharmacy to coordinate in-home product delivery
Providing ongoing education throughout the treatment journey
Download this guide to learn more about the full OnePath journey.
These materials are intended for adult patients or caregivers.
Sign up to receive ongoing updates and communications about upcoming events, treatment information, education, resources, and market research opportunities.
What is GATTEX?
GATTEX® (teduglutide) for subcutaneous injection is a prescription medicine used in adults and children 1 year of age and older with Short Bowel Syndrome (SBS) who need additional nutrition or fluids from intravenous (IV) feeding (parenteral support). It is not known if GATTEX is safe and effective in children under 1 year of age.
Important Safety Information
GATTEX may cause serious side effects, including making abnormal cells grow faster, polyps in the colon (large intestine), blockage of the bowel (intestines), swelling (inflammation) or blockage of your gallbladder or pancreas, and fluid overload. Click here for additional Important Safety Information.
Thank you! Please click the button below to download results or see the results here.